Clicky

TabletWise.com
    Pharmacy Website
    Clinic Website
     

    Intelligence » Chikungunya » Last Year

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    21 areas in Dhaka city most risky for Chikungunya

    Thursday, June 08, 2017 -- A total of 23 areas in Dhaka city were identified as most risky for Chikungunya disease, says a report.

    Not only joints, Chikungunya messes with your mind too

    Saturday, July 15, 2017 -- During the last two months, anticipations and suspense regarding the Chikungunya viral fever caused by Aedes Aegypti mosquito have gone viral. Half of the Dhakaites still are in physical pain left by the virus, half are half-relieved that they have been spared so far, and half-anxious about being the next victim.

    Help desks at all hospitals to tackle Chikungunya

    Monday, July 10, 2017 -- Health and Family Welfare Ministry directs all public hospitals and medical colleges across the country to open help desks to effectively tackle the already wide-spread Chikungunya menace, transmitted to humans by infected mosquitoes.

    First Chikungunya-infected Aedes aegypti mosquitos found in Brazil

    Friday, June 23, 2017 -- While more than 13,000 cases of Chikungunya viral disease were reported in Brazil in 2015, scientists had never before detected the virus in a captured mosquito in this country. Now, researchers reporting in PLOS Neglected Tropical Diseases have identified a mosquito–caught in the Brazilian city of Aracaju–that’s naturally infected with the East-Central-South-African (ECSA) genotype of […] The post First Chikungunya-infected Aedes aegypti mosquitos found in Brazil appeared first on Outbreak News Today.

    Chikungunya vaccine enters Phase I clinical trial

    Wednesday, March 14, 2018 -- Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, announced the initiation of a Phase I clinical trial in the U.S. to evaluate the safety and immunogenicity of VLA1553, its live-attenuated vaccine candidate against Chikungunya. The Phase I clinical trial is a randomized, observer-blinded, dose-escalation, multi-center study. It will […] The post Chikungunya vaccine enters Phase I clinical trial appeared first on Outbreak News Today.

    Don’t panic over Chikungunya: Doctors

    Thursday, May 18, 2017 -- Experts advise all not to panic over the outbreak of mosquito-borne Chikungunya, a menace that is a common household sickness in Dhaka nowadays.

    Dhaka chikungunya outbreak nears 3,000

    Friday, July 14, 2017 -- An outbreak of the mosquito borne viral disease, chikungunya (CHIKV), has struck Bangladesh’s capital of Dhaka, according to officials at the Institute of Epidemiology, Disease Control and Research (IEDCR). Since May, Dhaka has seen 2,700 CHIKV cases, which prompted IEDCR head, Professor Meerjady Sabrina Flora to say, “We’re currently facing a major outbreak of chikungunya”. “So far we […] The post Dhaka chikungunya outbreak nears 3,000 appeared first on Outbreak News Today.

    Italy: Chikungunya prompts suspension of blood donations in Rome

    Saturday, September 16, 2017 -- With an increase in the mosquito-borne viral infections caused by chikungunya in areas of Italy, the National Center for Blood (CNS) of the Higher Health Institute (ISS) suspended donations of blood and blood components in the municipality of Anzio and the Municipality of Rome, according to the health ministry (computer translated). Seventeen cases of the disease have […] The post Italy: Chikungunya prompts suspension of blood donations in Rome appeared first on Outbreak News Today.

    France reports two locally transmitted Chikungunya cases in the south

    Tuesday, August 22, 2017 -- French health officials reported two confirmed autochthonous chikungunya cases earlier this month, according to an ARS news release (computer translated). The cases were reported in the department of Var in Southern France. The first case who lives in Cannet-des-Maures in the Var district and works in the Alpes-Maritimes district had onset of symptoms on 1 August. The […] The post France reports two locally transmitted Chikungunya cases in the south appeared first on Outbreak News Today.

    More sickened in France's chikungunya outbreak

    Monday, August 28, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsAug 28, 2017The number of people sickened in France's outbreak has grown from 2 to 13.

    Researchers explore ability of Florida mosquitoes to transmit chikungunya virus

    Friday, July 28, 2017 -- University of Florida scientists are starting to better understand the ability of two Florida mosquito species to transmit two strains of chikungunya virus that have caused outbreaks of human disease around the world.

    Zika and chikungunya virus in a single mosquito bite

    Tuesday, June 13, 2017 -- Yellow fever mosquitos can carry both the Zika virus and the chikungunya virus in their saliva, which implies that people can be infected with both viruses in a single bite.

    ‘1 in 11 affected by chikungunya’ is fake news, IEDCR clarifies

    Monday, July 10, 2017 -- The Institute of Epidemiology, Disease Control and Research (IEDCR) has objected to the news about actual numbers of chikungunya affected people in Dhaka city.

    NIAID begins clinical trial for experimental chikungunya vaccine

    Saturday, June 10, 2017 -- With support from the NIH’s National Institute of Allergy and Infectious Diseases, a phase 1/2 trial of an experimental vaccine to combat chikungunya virus, known as MV-CHIKV, has begun enrollment at several vaccine and treatment evaluation units, according to a press release. The phase 1 trial, conducted by Themis Bioscience in Austria, showed that the MV-CHIKV vaccine was safe and induced an immune response. Modified from the measles vaccine virus, this experimental vaccine induces the production of both measles and chikungunya proteins once inside a human cell, stimulating the immune system to develop antibodies against these proteins that can potentially protect from infection.

    Monoclonal Antibody Reduces Symptoms Associated with Chikungunya Virus Infection

    Tuesday, August 15, 2017 -- Chikungunya virus is a mosquito-borne virus for which recent outbreaks in human populations have drawn a lot of interest from the scientific community. Luckily, a group of investigators recently reported the development of a monoclonal antibody with therapeutic potential in a macaque monkey model of the disease. Chikungunya virus (CHIKV) can be transmitted to […] The post Monoclonal Antibody Reduces Symptoms Associated with Chikungunya Virus Infection appeared first on Medical News Bulletin.

    Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand

    Thursday, June 29, 2017 -- by Sompong Vongpunsawad, Duangnapa Intharasongkroh, Thanunrat Thongmee, Yong Poovorawan The abundance of Aedes mosquito species enabled widespread transmission of mosquito-borne chikungunya virus (CHIKV) and dengue virus (DENV) in Southeast Asia. Periodic seroprevalence surveys are therefore necessary to assess the viral burden in the population and the effectiveness of public health interventions. Since the current seroprevalence for CHIKV and DENV in Thailand are unknown, we evaluated evidence of past infection among Thais. Eight-hundred and thirty-five serum samples obtained from individuals living in central and southern Thailand were assessed for anti-CHIKV and anti-DENV IgG antibodies using commercial enzyme-linked immunosorbent assays. Overall, 26.8% (224/835) of individuals were seropositive for CHIKV, the majority of whom were also DENV-seropositive (91.1%, 204/224). Approximately half of

    Chikungunya vaccine trial begins at Emory School of Medicine

    Monday, June 05, 2017 -- Emory University School of Medicine is one of three national sites participating in a Phase 1-2 clinical trial of an experimental vaccine to prevent infection with the chikungunya virus.

    France reports local chikungunya cluster

    Monday, August 21, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsAug 21, 2017In other developments, a few more cases were reported in the Americas and mosquito trials showed a risk of spread in major Kenyan cities.

    Austrian Biotech Kicks-off NIH-sponsored Trial of its Chikungunya Vaccine

    Tuesday, June 06, 2017 -- Themis Bioscience will test its vaccine candidate against Chikungunya fever in a new Phase I/II trial sponsored by the NIH. Based in Vienna, Themis Bioscience develops new vaccine candidates for emerging diseases like Zika and Chikungunya with its virus vaccine vector technology, which the ... This awesome article Austrian Biotech Kicks-off NIH-sponsored Trial of its Chikungunya Vaccine appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

    VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya

    Tuesday, March 13, 2018 -- Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Lyon (France), March 13, 2018 - Valneva SE, a fully integrated commercial stage biotech company focused on...